BIOREGEN is committed to becoming a leader of novel biomedical materials for wound repair in both domestic and overseas markets. The company mainly engages in R&D, production and sales of novel biomedical materials as well as drug sustained release agents. We aim to solve medical difficulties in the specialties of ENT, GYN, general surgery etc. and meet the needs of clinical departments.
Since we launched the oversea sale channels in 2014, BIOREGEN products have been spread throughout Asia, Europe and America, the Middle East and South America. BIOREGEN continues to explore the potential of international markets. We are willing to join hands with the world’s powerful dealers to achieve a win-win result.